½ÃÀ庸°í¼­
»óǰÄÚµå
1539331

Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Polycaprolactone Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ÃÖ±Ù ¼¼°è Æú¸®Ä«ÇÁ·Î¶ôÅæ(Polycaprolactone) ½ÃÀå¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ÅëÇØ ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ±íÀº ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ±Ô¸ð(2024³â) : 6¾ï 6,970¸¸ ´Þ·¯
  • ½ÃÀå ¿¹Ãø ±Ý¾×(2032³â) : 13¾ï 6,520¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2032³â CAGR) : 8.2%

Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå : Á¶»ç ¹üÀ§

Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀåÀº ƯÈ÷ »ýºÐÇØ¼º ÇÃ¶ó½ºÆ½, ¼öÁö ¹× ÀÇ·á±â±â Á¦Á¶¿¡ ÀÖ¾î ´Ù¾çÇÑ ¿ëµµ¿Í Á¦Ç°À» Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. Æú¸®Ä«ÇÁ·Î¶ôÅæ(PCL)Àº ÀúÀ¶Á¡ »ýºÐÇØ¼º Æú¸®¿¡½ºÅ׸£·Î ¿­°¡¼Ò¼º Æú¸®¿ì·¹Åº, ¹ÙÀÌ¿À¸ÞµðÄà Àç·á, ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ ¼ººÐÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¹ÙÀÌ¿À¸ÞµðÄà ºÐ¾ß, ÆÐŰ¡ »ê¾÷, Ư¼öÈ­ÇÐ µî ´Ù¾çÇÑ ºÎ¹®¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º Àç·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ±â¼ú ¹ßÀü, ´Ù¾çÇÑ »ê¾÷ °øÁ¤¿¡¼­ PCLÀÇ »ç¿ë È®´ë´Â »ýºÐÇØ¼º Àç·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:

¼¼°è Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀåÀ» À̲ô´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ȯ°æ ±ÔÁ¦¿Í ¼ÒºñÀÚ ÀνĿ¡ ÈûÀÔ¾î »ýºÐÇØ¼º ÇÃ¶ó½ºÆ½¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Æú¸®Ä«ÇÁ·Î¶ôÅæÀº ´Ù¸¥ Æú¸®¸Ó¿Í È¥ÇÕÇÒ ¼ö ÀÖ´Â ´ÙÀç´Ù´ÉÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ Æ÷Àå ¹× ÀÇ·á »ê¾÷¿¡¼­ ÀÀ¿ë ºÐ¾ß°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¶Á÷°øÇÐ, ¾à¹° Àü´Þ, ºÀÇÕ»ç µî »ý¹°ÀÇÇÐ ºÐ¾ß¿¡¼­ÀÇ ÀÀ¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ÒÀç´Â °¡°øÀÌ ¿ëÀÌÇÏ°í ´Ù¾çÇÑ Á¦Á¶ ±â¼ú¿¡ ÀûÇÕÇϱ⠶§¹®¿¡ ¸ÂÃãÇü ¹ÙÀÌ¿À ÀÇ·á±â±â Á¦Á¶¿¡ ¼±È£µÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀåÀÇ ²ÙÁØÇÑ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí PCL »ý»ê°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ´õ Àú·ÅÇÑ ´ëüǰÀÇ °¡¿ë¼º¿¡ ´ëÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Æú¸®Ä«ÇÁ·Î¶ôÅæÀÇ »ý»ê °øÁ¤Àº ±âÁ¸ Æú¸®¸Ó¿¡ ºñÇØ »ó´ëÀûÀ¸·Î ºñ½Î±â ¶§¹®¿¡ ºñ¿ë¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼­ÀÇ Ã¤ÅÃÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æú¸®À¯»ê(PLA)À̳ª Æú¸®ÇÏÀ̵å·Ï½Ã¾ËÄ«³ë¿¡ÀÌÆ®(PHA)¿Í °°Àº ´ëü »ýºÐÇØ¼º ¼ÒÀçÀÇ Á¸Àç´Â Á¾Á¾ Àú·ÅÇÑ °¡°ÝÀ¸·Î Á¦°øµÇ±â ¶§¹®¿¡ °æÀï·ÂÀÌ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠÁö¿ª¿¡¼­´Â PCLÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³·±â ¶§¹®¿¡ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

Æú¸®Ä«ÇÁ·Î¶ôÅæÀº ¾à¹° Àü´Þ ½Ã½ºÅÛ ¹× 3D ÇÁ¸°ÆÃ°ú °°Àº °íºÎ°¡°¡Ä¡ ÀÀ¿ë ºÐ¾ß¿¡¼­ äÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÃÀå¿¡´Â Å« ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× È¯ÀÚ ¸ÂÃãÇü ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, °³Àκ° ¸ÂÃãÈ­µÈ Ư¼ºÀ» Á¦°øÇÏ´Â PCL ±â¹Ý Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â°èÀû Ư¼º°ú »ýºÐÇØ¼ºÀ» Çâ»ó½Ã۵µ·Ï ¼³°èµÈ »õ·Î¿î PCL º¹ÇÕÀç ¹× ºí·»µå °³¹ßÀº ¹ÙÀÌ¿À¸ÞµðÄà ¹× ÆÐŰ¡ »ê¾÷¿¡¼­ Áõ°¡ÇÏ´Â ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¶ÇÇÑ, ¼øÈ¯ °æÁ¦¿Í Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ³ë·ÂÀÇ È®´ë´Â Æú¸®Ä«ÇÁ·Î¶ôÅæÀ» ±âÁ¸ ÇÃ¶ó½ºÆ½À» ´ëüÇÒ ¼ö Àִ ģȯ°æÀûÀÎ ´ë¾ÈÀ¸·Î ³Î¸® äÅÃÇÒ ¼ö ÀÖ´Â ºñ¿ÁÇÑ Åä¾çÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • Æú¸®Ä«ÇÁ·Î¶ôÅæÀÇ À¯Çü°ú ¿ëµµ´Â ´Ù¾çÇÑ »ê¾÷¿¡¼­ ¾î¶² À¯Çü°ú ¿ëµµ¸¦ äÅÃÇϰí Àִ°¡?
  • ±â¼ú ¹ßÀüÀº Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?
  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµð¿¡ ÀÖÀ¸¸ç, °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ¼¼°è ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î Æ®·»µå¿Í Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ¼­·Ð

  • ½ÃÀå ºÐ·ù
  • ½ÃÀå Á¤ÀÇ

Á¦3Àå ½ÃÀå ½ÃÁ¡

  • »óÀ§ ½ÃÀå Àü¸Á
  • ¹ë·ùüÀÎ ºÐ¼®
  • ¼ö¸íÁֱ⠺м®
  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ¿¡³ÊÁö ¿ä°Ç
  • ÁÖ¿ä ±ÔÁ¦
  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå µ¿Çâ
  • ½ÃÀå ±âȸ

Á¦5Àå ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

  • COVID-19 ÇöȲ
  • °¢±¹ ±¹°¡ ¶ô´Ù¿îÀÇ ¿µÇâ
  • COVID-19 À§±âÀÇ °æÁ¦¿¡ ´ëÇÑ ¿µÇ⠽󪸮¿À
  • Àü ¼¼°èÀûÀ¸·Î Äڷγª¹ÙÀÌ·¯½º À¯ÇàÀÇ ¿µÇâÀ» ¹Þ´Â ¾÷°è
  • °¡Àå Ÿ°ÝÀ» ¹ÞÀº ºÎ¹®ÀÇ È¸º¹ ¿¹Ãø
  • Äڷγª¹ÙÀÌ·¯½º°¡ ºñÁî´Ï½º ¼¼°è¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • COVID-19ÀÇ Á¦Á¶¾÷¿¡ ´ëÇÑ ¿µÇâ
  • Á¦Á¶¾÷ ±¸¸Å ´ã´çÀÚ Áö¼ö, 2024³â
  • COVID-19ÀÇ ¼¼°è °ø±Þ¸Á¿¡ ´ëÇÑ ¿µÇâ
  • COVID-19 ÆÒµ¥¹Í ±â°£ÀÇ °èȹ°ú °ü¸®
  • ºñÁî´Ï½º ¸®´õ°¡ ÁÖ¸ñÇØ¾ß ÇÒ ÇâÈÄ Áöħ

Á¦6Àå Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ°ú °¡Ä¡ : ±¹°¡º°, 2020³â
  • Æú¸®Ä«ÇÁ·Î¶ôÅæ ÆÇ¸Å ¿¹Ãø : COVID-19 ÆÒµ¥¹Í ¾È, 2020³â
  • COVID-19 ÀÌÀü ½ÃÀå ¿¹Ãø v/s COVID-19 ÀÌÈÄ ½ÃÀå ¿¹Ãø

Á¦7Àå ¼¼°èÀÇÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

  • ¼­·Ð
    • ½ÃÀå ¸ÅÃâ ¿¹Ãø
    • ½ÃÀå ±Ô¸ð(MT) ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ë¾× ±âȸ
  • ¼¼°è °¡°Ý ºÐ¼®
  • °­µµ ¸ÅÇÎ

Á¦8Àå ¼¼°èÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼® : Çüź°

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼® : Çüź°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼®°ú ¿¹Ãø : Çüź°, 2024³â-2032³â
    • Æç¸´
    • ³ª³ë±¸
    • ¸¶ÀÌÅ©·Î½ºÇǾî
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Çüź°

Á¦9Àå ¼¼°èÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼® : »ý»ê ¹æ¹ýº°

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼® : »ý»ê ¹æ¹ýº°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼®°ú ¿¹Ãø : »ý»ê ¹æ¹ýº°, 2024³â-2032³â
    • Ring Opening polymerization
    • Polycondesation of carboxylic acid
  • Àå¼Ò ¸Å·Â ºÐ¼® : »ý»ê ¹æ¹ýº°

Á¦10Àå ¼¼°èÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼® : ¿ëµµº°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°, 2024³â-2032³â
    • ¿­°¡¼Ò¼º Æú¸®¿ì·¹Åº
    • ÇコÄɾî
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Ç÷§Æûº°

Á¦11Àå ¼¼°èÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼® : Áö¿ªº°, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°, 2024³â-2032³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • µ¿³²¾Æ½Ã¾Æ ¹× ÅÂÆò¾ç(SEAP)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • ÀϺ»
    • Áß±¹
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦12Àå ºÏ¹ÌÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦14Àå À¯·´ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦15Àå µ¿³²¾Æ½Ã¾Æ ¹× ÅÂÆò¾ç(SEAP)ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦16Àå Áß±¹ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ºÐ¼® : ½ÃÀå ºÎ¹®º°, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·®(¹ÌÅÍ) ¿¹Ãø : ½ÃÀå ºÎ¹®º°, 2024³â-2032³â
    • Çüź°
    • »ý»ê ¹æ¹ýº°
    • ¿ëµµº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦17Àå ÀϺ»ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦18Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)ÀÇ Æú¸®Ä«ÇÁ·Î¶ôÅæ ½ÃÀå ºÐ¼®

Á¦19Àå °æÀï ±¸µµ(Á¦Á¶¾÷)

  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • °æÀï ±¸µµ
  • ½ÃÀå ¼ö·® Á¡À¯À² ºÐ¼®
  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Perstorp Holding A. B.
    • BASF SE
    • Diacel Corporation
    • Sigma-Aldrich Corporation(Merck)
    • Durect Corporation
    • Corbion Purac
    • Shenzen Esun Industrial Co. Ltd.
    • Haihang Industries Co., Ltd.
    • Polysciences, Inc.
    • Shenzhen Polymtek Biomaterial Co. Ltd.

Á¦20Àå Á¶»ç ¹æ¹ý

Á¦21Àå ÀüÁ¦Á¶°Ç°ú »ç¿ëµÇ´Â µÎÀÚ¾î

LSH 24.09.19

Persistence Market Research has recently published an extensive report on the global Polycaprolactone Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Polycaprolactone Market Size (2024E): USD 669.7 Mn
  • Projected Market Value (2032F): USD 1,365.2 Mn
  • Global Market Growth Rate (CAGR 2024 to 2032): 8.2%

Polycaprolactone Market - Report Scope:

The Polycaprolactone Market encompasses a variety of applications and products, particularly in the manufacturing of biodegradable plastics, resins, and medical devices. Polycaprolactone (PCL) is a biodegradable polyester with a low melting point, widely used in the production of thermoplastic polyurethanes, biomedical materials, and as a component in drug delivery systems. The market caters to diverse segments, including the biomedical sector, packaging industry, and specialty chemicals. Growth is driven by increasing environmental concerns leading to the demand for biodegradable materials, advancements in medical technology, and the expanding application of PCL in various industrial processes.

Market Growth Drivers:

Several key factors are driving the global Polycaprolactone Market. The rising demand for biodegradable plastics, spurred by environmental regulations and consumer awareness, significantly boosts the market. Polycaprolactone's versatility in blending with other polymers enhances its application in the packaging and medical industries. Additionally, the growing biomedical applications, particularly in tissue engineering, drug delivery, and sutures, further fuel market expansion. The material's ease of processing and compatibility with various manufacturing techniques make it a preferred choice for creating custom-designed biomedical devices, which supports the market's steady growth.

Market Restraints:

Despite promising growth prospects, the Polycaprolactone Market faces challenges related to the high costs associated with PCL production and the availability of cheaper alternatives. The production process for polycaprolactone can be more expensive compared to conventional polymers, which can limit its adoption in cost-sensitive markets. Furthermore, the presence of alternative biodegradable materials, such as polylactic acid (PLA) and polyhydroxyalkanoates (PHA), may pose competition, as they are often available at lower costs. Additionally, the market's growth may be hindered by the limited awareness of PCL's benefits in some regions, necessitating greater educational and marketing efforts to promote its advantages.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of polycaprolactone in high-value applications, such as drug delivery systems and 3D printing. The growing demand for personalized medicine and patient-specific implants creates opportunities for PCL-based products, which offer customizable properties tailored to individual needs. The development of novel PCL composites and blends, designed to enhance mechanical properties and biodegradability, is expected to cater to the growing demand in the biomedical and packaging industries. Moreover, the expansion of the circular economy and sustainability initiatives provides a fertile ground for the broader adoption of polycaprolactone as an eco-friendly alternative to traditional plastics.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Polycaprolactone Market globally?
  • Which types and applications of polycaprolactone are leading the adoption in various industries?
  • How are technological advancements influencing the competitive landscape of the Polycaprolactone Market?
  • Who are the key players in the Polycaprolactone Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Polycaprolactone Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Polycaprolactone Market, including BASF SE, Corbion N.V., and Perstorp Holding AB, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced PCL products and explore new applications in high-growth markets. Collaborations with academic institutions, research organizations, and industry stakeholders facilitate market access and promote new product adoption. Emphasis on sustainability, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Polycaprolactone Market landscape.

Key Companies Profiled:

  • Perstorp Holding A. B.
  • BASF SE
  • Diacel Corporation
  • Sigma-Aldrich Corporation (Merck)
  • Durect Corporation
  • Corbion Purac
  • Shenzen Esun Industrial Co. Ltd.
  • Haihang Industries Co., Ltd.
  • Polysciences, Inc.
  • Shenzhen Polymtek Biomaterial Co. Ltd.

Polycaprolactone Market Industry Segmentation:

Form

  • Pellets
  • Nanosphere
  • Microsphere

Production Method

  • Ring Opening Polymerization
  • Polycondesation of Carboxylic Acid

Application

  • Thermoplastic Polyurethane
  • Healthcare
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South East Asia & Pacific
  • MEA
  • Japan
  • China

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Market Viewpoint

  • 3.1. Parent Market Outlook
  • 3.2. Value Chain Analysis
  • 3.3. Life Cycle Analysis
  • 3.4. Energy Requirement for Polycaprolactone
  • 3.5. Key Regulation
  • 3.6. Macro-economic Factors
  • 3.7. Forecast Factors: Relevance and Impact

4. Market Dynamics

  • 4.1. Market Driver
  • 4.2. Market Restraints
  • 4.3. Market Trend
  • 4.4. Market opportunity

5. Impact of Covid-19 on Market

  • 5.1. Covid-19 The Situation Now
  • 5.2. Effects of National Lockdowns in Various Countries
  • 5.3. Scenarios for Economic Impact of Covid-19 Crisis
  • 5.4. Industries Affected by Coronavirus Outbreak Worldwide
  • 5.5. Projected Recovery for Hardest Hit Sectors
  • 5.6. Coronavirus Impact on The World of Work
  • 5.7. Impact of Covid-19 on Manufacturing Industry
  • 5.8. Manufacturing Purchasing Managers Index, 2024
  • 5.9. Impact of Covid-19 on Supply Chain Worldwide
  • 5.10. Planning & Managing During Covid-19 Pandemic
  • 5.11. Upcoming Pointers Business Leaders Should Focus On

6. Impact of Covid-19 on Polycaprolactone Market

  • 6.1. Covid-19 Impact v/s Value of Polycaprolactone Market, by Country 2020
  • 6.2. Polycaprolactone Sales Projection, 2020 During Covid-19 Pandemic
  • 6.3. Pre Covid-19 Market Forecasts v/s Post Covid-19 Market Forecasts

7. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 7.1. Introduction
    • 7.1.1. Market Value Projections
    • 7.1.2. Market Volume (MT) Projections
    • 7.1.3. Market Size and Y-o-Y Growth
    • 7.1.4. Absolute $ Opportunity
  • 7.2. Global Pricing Analysis
  • 7.3. Intensity Mapping

8. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Form

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Form, 2019-2023
  • 8.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Form, 2024-2032)
    • 8.3.1. Pellets
    • 8.3.2. Nano sphere
    • 8.3.3. Microsphere
  • 8.4. Market Attractiveness Analysis By Form

9. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Production Method

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Production Method, 2019-2023
  • 9.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Production Method, 2024-2032)
    • 9.3.1. Ring Opening polymerization
    • 9.3.2. Polycondesation of carboxylic acid
  • 9.4. Market Attractiveness Analysis By Production Method

10. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Application, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Application, 2024-2032)
    • 10.3.1. Thermoplastic polyurethane
    • 10.3.2. Healthcare
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis By Platform

11. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 11.1. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Region, 2019-2023
  • 11.2. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Region, 2024-2032
    • 11.2.1. North America
    • 11.2.2. Latin America
    • 11.2.3. Europe
    • 11.2.4. South East Asia & Pacific (SEAP)
    • 11.2.5. Middle East & Africa (MEA)
    • 11.2.6. Japan
    • 11.2.7. China
  • 11.3. Market Attractiveness Analysis By Region

12. North America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 12.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Form
    • 12.3.3. By Production method
    • 12.3.4. By Application
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Form
    • 12.4.3. By Production method
    • 12.4.4. By Application

13. Latin America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 13.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Rest of Latin America
    • 13.3.2. By Form
    • 13.3.3. By Production method
    • 13.3.4. By Application
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By Production method
    • 13.5.4. By Application

14. Europe Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 14.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. U.K.
      • 14.3.1.4. Italy
      • 14.3.1.5. Russia
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Nordic countries
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Form
    • 14.3.3. By Production method
    • 14.3.4. By Application
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Form
    • 14.4.3. By Production method
    • 14.4.4. By Application

15. South East Asia & Pacific (SEAP) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 15.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 15.3.1. By Country
      • 15.3.1.1. ASEAN
      • 15.3.1.2. India
      • 15.3.1.3. Korea
      • 15.3.1.4. ANZ
      • 15.3.1.5. Rest of SEAP
    • 15.3.2. By Form
    • 15.3.3. By Production method
    • 15.3.4. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Form
    • 15.4.3. By Production method
    • 15.4.4. By Application

16. China Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 16.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 16.3.1. By Form
    • 16.3.2. By Production method
    • 16.3.3. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Form
    • 16.4.2. By Production method
    • 16.4.3. By Application

17. Japan Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 17.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 17.3.1. By Form
    • 17.3.2. By Production method
    • 17.3.3. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Form
    • 17.4.2. By Production method
    • 17.4.3. By Application

18. Middle East & Africa (MEA) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 18.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 18.3.1. By Country
      • 18.3.1.1. GCC
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East & Africa
    • 18.3.2. By Form
    • 18.3.3. By Production method
    • 18.3.4. By Application
  • 18.4. Drivers and Restraints: Impact Analysis
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Form
    • 18.5.3. By Production method
    • 18.5.4. By Application

19. Competition Landscape (Manufactures)

  • 19.1. Market Share Analysis
  • 19.2. Competitive Landscape
  • 19.3. Market Volume share analysis
  • 19.4. Competition Dashboard
  • 19.5. Company Profiles
    • 19.5.1. Perstorp Holding A. B.
      • 19.5.1.1. Overview
      • 19.5.1.2. Product Portfolio
      • 19.5.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.1.4. Production Footprint
      • 19.5.1.5. Sales Footprint
      • 19.5.1.6. Channel Footprint
      • 19.5.1.7. Strategy Overview
        • 19.5.1.7.1. Marketing Strategy
        • 19.5.1.7.2. Product Strategy
        • 19.5.1.7.3. Channel Strategy
    • 19.5.2. BASF SE
      • 19.5.2.1. Overview
      • 19.5.2.2. Product Portfolio
      • 19.5.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.2.4. Production Footprint
      • 19.5.2.5. Sales Footprint
      • 19.5.2.6. Channel Footprint
      • 19.5.2.7. Strategy Overview
        • 19.5.2.7.1. Marketing Strategy
        • 19.5.2.7.2. Product Strategy
        • 19.5.2.7.3. Channel Strategy
    • 19.5.3. Diacel Corporation
      • 19.5.3.1. Overview
      • 19.5.3.2. Product Portfolio
      • 19.5.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.3.4. Production Footprint
      • 19.5.3.5. Sales Footprint
      • 19.5.3.6. Channel Footprint
      • 19.5.3.7. Strategy Overview
        • 19.5.3.7.1. Marketing Strategy
        • 19.5.3.7.2. Product Strategy
        • 19.5.3.7.3. Channel Strategy
    • 19.5.4. Sigma-Aldrich Corporation (Merck)
      • 19.5.4.1. Overview
      • 19.5.4.2. Product Portfolio
      • 19.5.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.4.4. Production Footprint
      • 19.5.4.5. Sales Footprint
      • 19.5.4.6. Channel Footprint
      • 19.5.4.7. Strategy Overview
        • 19.5.4.7.1. Marketing Strategy
        • 19.5.4.7.2. Product Strategy
        • 19.5.4.7.3. Channel Strategy
    • 19.5.5. Durect Corporation
      • 19.5.5.1. Overview
      • 19.5.5.2. Product Portfolio
      • 19.5.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.5.4. Production Footprint
      • 19.5.5.5. Sales Footprint
      • 19.5.5.6. Channel Footprint
      • 19.5.5.7. Strategy Overview
        • 19.5.5.7.1. Marketing Strategy
        • 19.5.5.7.2. Product Strategy
        • 19.5.5.7.3. Channel Strategy
    • 19.5.6. Corbion Purac
      • 19.5.6.1. Overview
      • 19.5.6.2. Product Portfolio
      • 19.5.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.6.4. Production Footprint
      • 19.5.6.5. Sales Footprint
      • 19.5.6.6. Channel Footprint
      • 19.5.6.7. Strategy Overview
        • 19.5.6.7.1. Marketing Strategy
        • 19.5.6.7.2. Product Strategy
        • 19.5.6.7.3. Channel Strategy
    • 19.5.7. Shenzen Esun Industrial Co. Ltd.
      • 19.5.7.1. Overview
      • 19.5.7.2. Product Portfolio
      • 19.5.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.7.4. Production Footprint
      • 19.5.7.5. Sales Footprint
      • 19.5.7.6. Channel Footprint
      • 19.5.7.7. Strategy Overview
        • 19.5.7.7.1. Marketing Strategy
        • 19.5.7.7.2. Product Strategy
        • 19.5.7.7.3. Channel Strategy
    • 19.5.8. Haihang Industries Co., Ltd.
      • 19.5.8.1. Overview
      • 19.5.8.2. Product Portfolio
      • 19.5.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.8.4. Production Footprint
      • 19.5.8.5. Sales Footprint
      • 19.5.8.6. Channel Footprint
      • 19.5.8.7. Strategy Overview
        • 19.5.8.7.1. Marketing Strategy
        • 19.5.8.7.2. Product Strategy
        • 19.5.8.7.3. Channel Strategy
    • 19.5.9. Polysciences, Inc.
      • 19.5.9.1. Overview
      • 19.5.9.2. Product Portfolio
      • 19.5.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.9.4. Production Footprint
      • 19.5.9.5. Sales Footprint
      • 19.5.9.6. Channel Footprint
      • 19.5.9.7. Strategy Overview
        • 19.5.9.7.1. Marketing Strategy
        • 19.5.9.7.2. Product Strategy
        • 19.5.9.7.3. Channel Strategy
    • 19.5.10. Shenzhen Polymtek Biomaterial Co. Ltd.
      • 19.5.10.1. Overview
      • 19.5.10.2. Product Portfolio
      • 19.5.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.10.4. Production Footprint
      • 19.5.10.5. Sales Footprint
      • 19.5.10.6. Channel Footprint
      • 19.5.10.7. Strategy Overview
        • 19.5.10.7.1. Marketing Strategy
        • 19.5.10.7.2. Product Strategy
        • 19.5.10.7.3. Channel Strategy

20. Research Methodology

21. Assumption & Acronyms Used

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦